Dexamethasone 20 MG/5 ML vial 5ML
Ended Awarded
- Contract number
- SPE2DB26FY1V3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,058
Award facts
- Contract value 100% obligated
- $1,058.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $1,058.01. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain. The company supplies a wide spectrum of medications and medical commodities across multiple therapeutic domains, including specialty pharmaceuticals, vaccines, and medical supplies. This particular delivery order for dexamethasone—a corticosteroid commonly used in military and veteran healthcare systems—reflects the routine pharmaceutical procurement operations that characterize the company's ongoing relationship with the DLA and demonstrates its capability to fulfill federal medical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB26FY1V3?
SPE2DB26FY1V3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FY1V3 worth?
The government has obligated $1,058 on SPE2DB26FY1V3.
Is contract SPE2DB26FY1V3 an order under another contract?
Yes. SPE2DB26FY1V3 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1V3 competed?
The extent of competition for SPE2DB26FY1V3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award